← All entities

Drug Policy

Tracking since May 19, 2026 · Latest signal Apr 24, 2026 · 75 matched data points

Overall sentiment

Positive 47% (35)Negative 11% (8)Neutral 43% (32)

Daily sentiment

Claims (16)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

The reclassification of medical marijuana as a less-dangerous drug under Schedule III is a significant shift in federal drug policy.
Parent: Drug PolicyEntity: Medical Marijuana ReschedulingImpact: positiveDate: Apr 23, 2026Target: The reclassification of medical marijuana as a less-dangerous drug under Schedule III19 matched entries14 confirmed0 disputed5 neutral0 unclear
Reclassifying marijuana as a less dangerous drug could be a significant step in altering current drug policy.
Parent: Drug PolicyEntity: Marijuana ReclassificationImpact: positiveDate: Apr 24, 2026Target: Reclassifying marijuana as a less dangerous drug7 matched entries0 confirmed0 disputed7 neutral0 unclear
A majority of U.S. adults have used marijuana recreationally, with significant variation across political affiliations and age groups.
Parent: Drug PolicyEntity: Marijuana UseImpact: neutralDate: Apr 20, 2026Target: Majority recreational marijuana use among U.S. adults6 matched entries4 confirmed0 disputed2 neutral0 unclear
A notable portion of U.S. adults have used medical marijuana, with differences observed across political affiliations and age groups.
Parent: Drug PolicyEntity: Medical MarijuanaImpact: neutralDate: Apr 20, 2026Target: Medical marijuana usage among U.S. adults6 matched entries3 confirmed0 disputed3 neutral0 unclear
Trump is set to reclassify marijuana, which would alter its legal status and regulatory framework.
Parent: Drug PolicyEntity: Marijuana ReclassificationImpact: negativeDate: Apr 22, 2026Target: Trump's reclassification of marijuana5 matched entries1 confirmed0 disputed4 neutral0 unclear
President Trump has directed his administration to accelerate the review process for certain psychedelic substances.
Parent: Drug PolicyEntity: Psychedelic SubstancesImpact: positiveDate: Apr 18, 2026 - Apr 19, 2026Target: President Trump's directive to expedite the review of psychedelic substances4 matched entries4 confirmed0 disputed0 neutral0 unclear
The Dutch government believes that the ease of purchasing cannabis two years after legalization is a problem.
Parent: Drug PolicyEntity: Cannabis Legalization in the NetherlandsImpact: negativeDate: Apr 19, 2026 - Apr 20, 2026Target: The ease of purchasing cannabis two years after legalization4 matched entries4 confirmed0 disputed0 neutral0 unclear
Authorities in Trenque Lauquen followed established procedures when incinerating over 175 kilograms of marijuana and other seized drugs.
Parent: Drug PolicyEntity: Drug Incineration ProceduresImpact: positiveDate: Apr 19, 2026Target: Proper handling of illegal substances by law enforcement3 matched entries3 confirmed0 disputed0 neutral0 unclear
The Trump administration made cannabis regulations more permissive.
Parent: Drug PolicyEntity: Trump administration cannabis regulationsImpact: positiveDate: Apr 23, 2026Target: The Trump administration made cannabis regulations more permissive.3 matched entries3 confirmed0 disputed0 neutral0 unclear
The Trump administration reclassified medical marijuana as a less dangerous drug.
Parent: Drug PolicyEntity: Trump AdministrationImpact: positiveDate: Apr 23, 2026Target: The reclassification of medical marijuana as a less dangerous drug by the Trump administration.3 matched entries3 confirmed0 disputed0 neutral0 unclear
The U.S. government reclassified medicinal marijuana authorized by states as a less dangerous substance under Trump's administration.
Parent: Drug PolicyEntity: Marijuana RegulationImpact: positiveDate: Apr 23, 2026 - Apr 24, 2026Target: The reclassification of marijuana as a less dangerous substance3 matched entries3 confirmed0 disputed0 neutral0 unclear
The White House is advocating for the immediate relaxation of federal regulations on marijuana.
Parent: Drug PolicyEntity: Marijuana RegulationImpact: positiveDate: Apr 22, 2026Target: The White House's proposal to ease marijuana controls3 matched entries3 confirmed0 disputed0 neutral0 unclear
The compound CI-581, also known as ketamine, has transitioned from a medical analgesic to a recreational drug and is now being promoted as an antidepressant.
Parent: Drug PolicyEntity: KetamineImpact: negativeDate: Apr 23, 2026Target: The compound CI-581's role as a recreational drug and its use as an antidepressant.3 matched entries3 confirmed0 disputed0 neutral0 unclear
Donald Trump's executive order aims to increase the accessibility of certain psychedelic substances for therapeutic use.
Parent: Drug PolicyEntity: Psychedelic SubstancesImpact: positiveDate: Apr 19, 2026 - Apr 20, 2026Target: Donald Trump's executive order to increase the accessibility of certain psychedelic substances for therapeutic use.2 matched entries0 confirmed0 disputed2 neutral0 unclear
The Trump administration is expected to reclassify marijuana as a less controlled substance.
Parent: Drug PolicyEntity: Marijuana ReclassificationImpact: positiveDate: Apr 22, 2026Target: The reclassification of marijuana2 matched entries2 confirmed0 disputed0 neutral0 unclear
The Trump administration's decision to reclassify certain drugs will impact access to medications and regulatory oversight.
Parent: Drug PolicyEntity: Trump administration drug reclassificationsImpact: mixedDate: Apr 20, 2026Target: The Trump administration's decision to reclassify certain drugs2 matched entries0 confirmed0 disputed2 neutral0 unclear